Reducing Bacterial Adhesion And Biofouling On Medical Device Surfaces: An Interview With Jeannette Ho
Source: Evonik Corporation
The Endexo® surface modification technology has been extensively studied and commercially used for improving the blood compatibility of medical devices to reduce thrombosis risk. However, its potential to reduce bacterial adhesion of multiple bacterial species, and overall biofouling on device surfaces, is only now starting to be recognized. This interview with Jeannette Ho, the Head of Surface Modification at Evonik, discusses opportunities for medical device companies to leverage this passive, stable and durable technology platform to reduce bacterial adhesion and biofouling.
access the Q&A!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Med Device Online? Subscribe today.
Subscribe to Med Device Online
X
Subscribe to Med Device Online
Evonik Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more